Last week, a Canadian judge ruled that addicts have a human right to access a legal supply of currently prohibited substances—such as cocaine, heroin, fentanyl, and meth—and that, by extension, criminalizing drug trafficking is unconstitutional. Though the ruling is clear judicial activism, it could nevertheless impose drug legalization across Canada unless it successfully appealed.
The case concerns Jeremy Kalicum and Eris Nyx, who operated a “compassion club” on behalf of the Drug User Liberation Front (DULF), an addict-led activist group based in Vancouver, British Columbia. Through this initiative, Kalicum and Nyx purchased illicit substances off the dark web, tested them for adulterants, and then sold them at cost to vetted users in clearly marked packaging. The pair thought that they could reduce overdoses by supplying club members with drugs of a known quantity, potency, and purity, in contrast with the unpredictable street supply.
Finally, a reason to check your email.
Sign up for our free newsletter today.
Kalicum and Nyx were transparent about their operations, which received significant media attention. British Columbia’s provincial government was fully aware of them, as were Vancouver’s police and public health authorities. Federal and provincial health authorities even granted them a legal exemption to provide drug-checking and supervised-consumption services. They also gave the pair $200,000 in public funding, which Kalicum and Nyx claimed they didn’t use for illicit drug purchases.
In partnership with Canadian harm-reduction activist-researchers, DULF conducted low-quality research into the effects of their compassion club. They interviewed members about their experiences, then portrayed these glowing testimonials as evidence of success. For example, participants reported that they consumed fewer drugs and overdosed less often, but 55 percent admitted to diverting their drugs to outsiders at least once. Though the sample sizes were tiny and there was no control group or random selection of participants, these “studies” were published in ideologically aligned harm-reduction journals.
In late 2023, amid a public backlash against British Columbia’s lax drug policies, police raided DULF’s premises and found packaged cocaine, heroin, and meth. Authorities charged Kalicum and Nyx with drug trafficking, for which there is no exemption under Canadian law. After their convictions on these charges in late 2025, Kalicum and Nyx appealed to British Columbia’s Supreme Court on the grounds that prohibiting “benevolent” drug trafficking is unconstitutional.
In Canada, such disputes typically concern the Canadian Charter of Rights and Freedoms, adopted as part of the Constitution Act of 1982. Greatly expanding judicial power, the Charter guarantees Canadians certain political and civil rights—though it includes a “notwithstanding clause” that allows provincial and federal legislators temporarily to override some rights to thwart judicial overreach.
Charter rights are often vaguely worded and open to broad interpretation. This has allowed activist judges to increasingly invent new sub-rights on specious grounds, typically by invoking Section 7 of the Charter, which guarantees the “right to life, liberty, and security of the person.” For example, a 2024 Ontario Superior Court ruling essentially claimed that addicts have a constitutional right to use drugs in homeless shelters. A 2025 ruling in that same court claimed a constitutional right to bike lanes (the latter ruling was eventually overturned on appeal).
Kalicum and Nyx argued that Canada’s laws against trafficking-related drug possession are invalid because they violate the Charter—specifically Section 7 and Section 15 (the right to equal treatment under the law without discrimination). They argued that, because street substances are dangerously unpredictable, addicts cannot enjoy their right to life and security of the person unless they have access to a regulated “safer supply” of drugs. Further, they claimed that, as Canadian law treats addiction as a disability, exposing addicts to the danger of street drugs (as opposed to a legal “safer supply”) amounts to discrimination.
Incredibly, Justice Catherine Murray of the B.C. Supreme Court agreed with their arguments. In her ruling last week, she threw out the charges against Kalicum and Nyx, deemed federal prohibition on the possession of drugs for the purpose of trafficking unconstitutional, and repeatedly declared—without real evidence—an urgent need for “non-medicalized safer supply” (a term that essentially means drug legalization).
A close reading suggests that the decision was the product of the government prosecutors’ ineptitude and the judge’s credulousness. As noted in Justice Murray’s ruling, the prosecutors did not present any of their own experts during the appeal—a strange omission, given the plethora of drug policy scholars who oppose legalization and radical harm reductionism. That means Justice Murray listened only to one side of the debate, as represented by the most prominent and arguably most ideological voices within Canada’s harm-reduction movement.
One would hope that these circumstances would lead a judge to exercise intellectual caution. For example, the prosecutors argued that DULF’s studies were too flawed to show reliably that the compassion club saved lives. But Justice Murray dismissed these concerns because, she claimed, such research shortcomings are “unavoidable.” Junk science, though, does not become reliable simply because serious research is impractical or unavailable.
Murray also specifically dismissed concerns about whether DULF’s studies were vulnerable to response bias (such as addicts giving researchers inaccurate answers for personal motivations). She noted that Kalicum and Nyx had “repeatedly advised members of the need to be candid,” and that two compassion club members had testified in court that they “felt free to be candid.” That was enough evidence for Murray to conclude that the respondents were telling the truth.
Researchers cannot fix response bias by imploring research subjects to be honest. If this were the case, then response bias would never be a problem. Similarly, no sane policymaker or judge should believe that frequent drug users—who are known to lie and manipulate those around them to acquire drugs—are being honest simply because they say so. In fact, a 2024 study conducted by Vancouver’s Infectious Disease Centre showed, via urine tests, that drug users regularly deceive researchers about whether they are defrauding harm-reduction programs.
Justice Murray’s ruling repeatedly asserts that it is an indisputable fact that Canada urgently needs “non-medicalized safer supply.” To support her claim, she cited several high-profile reports from British Columbia that recommend this option. But none of these reports provides supporting evidence.
Take, for example, a 2024 report by British Columbia’s top doctor, Bonnie Henry. The report explicitly acknowledges that “little published information” exists on drug legalization. It instead resorts to speculation and conjecture to fill this evidentiary void, citing “medicalized safer supply”—an experimental Canadian harm-reduction program that gives addicts, via prescription, free drugs as an alternative to the riskier street supply. Typically, that means handing out massive volumes of hydromorphone, a heroin-strength opioid, with minimal supervision.
But since becoming widely available in 2020, Canada’s “medicalized” safer supply experiment has been a disaster. There is ample evidence that participants divert a significant portion of their free hydromorphone to the black market, flooding communities with the drug to the benefit of organized crime. Conversely, there is no reliable evidence that “medicalized” safer supply is beneficial. Most supporting studies, like DULF’s research, exclusively rely on addict testimonials, which are presented as objective evidence of success. A small number of studies use higher-quality data but have been criticized for alleged data manipulation.
Henry’s report points to Canada’s experiment in “medicalized safer supply” as a reason to embrace “unmedicalized” safer supply (drug legalization), but this is unsupportable. “Medicalized” safer supply has been an unscientific failure, and the “unmedicalized” model is a radically different concept—one cannot extrapolate evidence for the latter from the former.
Nonetheless, Murray treated this report and others like it as ironclad proof that drug legalization is urgently needed. She took it upon herself to impose an enormously consequential and highly contentious drug policy reform through judicial fiat.
Thankfully, the case can still be appealed. It could eventually reach the Supreme Court of Canada, which seems likely to overturn it, especially if the government’s prosecutors do their job properly. Alternatively, the federal government can invoke the Charter’s “notwithstanding clause” to immunize its drug-trafficking laws from judicial interference.
None of these remedies would be necessary in a more rational world, but, alas, such steps are necessary in the face of Canadian judicial activism.